JPWO2021142145A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021142145A5
JPWO2021142145A5 JP2022541787A JP2022541787A JPWO2021142145A5 JP WO2021142145 A5 JPWO2021142145 A5 JP WO2021142145A5 JP 2022541787 A JP2022541787 A JP 2022541787A JP 2022541787 A JP2022541787 A JP 2022541787A JP WO2021142145 A5 JPWO2021142145 A5 JP WO2021142145A5
Authority
JP
Japan
Prior art keywords
radical
group
inflammation
betamethasone
dexamethasone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022541787A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510741A (ja
JP2023510741A5 (https=
JP7678813B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012532 external-priority patent/WO2021142145A1/en
Publication of JP2023510741A publication Critical patent/JP2023510741A/ja
Publication of JPWO2021142145A5 publication Critical patent/JPWO2021142145A5/ja
Publication of JP2023510741A5 publication Critical patent/JP2023510741A5/ja
Priority to JP2025076816A priority Critical patent/JP2025118775A/ja
Application granted granted Critical
Publication of JP7678813B2 publication Critical patent/JP7678813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022541787A 2020-01-07 2021-01-07 標的指向性ステロイド化合物 Active JP7678813B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076816A JP2025118775A (ja) 2020-01-07 2025-05-02 標的指向性ステロイド化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062958102P 2020-01-07 2020-01-07
US62/958,102 2020-01-07
US202063030020P 2020-05-26 2020-05-26
US63/030,020 2020-05-26
PCT/US2021/012532 WO2021142145A1 (en) 2020-01-07 2021-01-07 Targeted steroid conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076816A Division JP2025118775A (ja) 2020-01-07 2025-05-02 標的指向性ステロイド化合物

Publications (4)

Publication Number Publication Date
JP2023510741A JP2023510741A (ja) 2023-03-15
JPWO2021142145A5 true JPWO2021142145A5 (https=) 2024-01-17
JP2023510741A5 JP2023510741A5 (https=) 2024-01-17
JP7678813B2 JP7678813B2 (ja) 2025-05-16

Family

ID=76787625

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541787A Active JP7678813B2 (ja) 2020-01-07 2021-01-07 標的指向性ステロイド化合物
JP2025076816A Pending JP2025118775A (ja) 2020-01-07 2025-05-02 標的指向性ステロイド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076816A Pending JP2025118775A (ja) 2020-01-07 2025-05-02 標的指向性ステロイド化合物

Country Status (11)

Country Link
US (1) US20230331767A1 (https=)
EP (1) EP4087580A4 (https=)
JP (2) JP7678813B2 (https=)
KR (1) KR20220124742A (https=)
CN (1) CN115003308A (https=)
AU (1) AU2021205255A1 (https=)
BR (1) BR112022013478A2 (https=)
CA (1) CA3163268A1 (https=)
IL (2) IL326516A (https=)
MX (1) MX2022008343A (https=)
WO (1) WO2021142145A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115232186B (zh) * 2022-07-07 2024-03-01 武汉工程大学 一种泼尼松磷酸酯及其盐的制备方法和应用
WO2024025845A1 (en) * 2022-07-25 2024-02-01 Sorrento Therapeutics, Inc. Folate-conjugated drugs and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379698B1 (en) * 1999-04-06 2002-04-30 Isis Pharmaceuticals, Inc. Fusogenic lipids and vesicles
CA2503094A1 (en) * 2002-02-27 2003-09-04 The Ohio State University Research Foundation Therapeutic methods for acute myeloid leukemia
US20070009434A1 (en) * 2005-07-05 2007-01-11 Low Philip S Imaging and therapeutic method using monocytes
WO2007139815A2 (en) * 2006-05-23 2007-12-06 Purdue Research Foundation Imaging and therapeutic method using progenitor cells
EP2231194B1 (en) * 2007-12-04 2017-02-22 Alnylam Pharmaceuticals Inc. Folate-irna conjugates
CA2800693A1 (en) * 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
EP2908818A4 (en) * 2012-10-16 2016-07-13 Endocyte Inc CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
MY195114A (en) * 2016-02-04 2023-01-10 Robert Yongxin Zhao Specific Conjugation Linkers, Specific Immunoconjugates Thereof, Methods of Making and uses Such Conjugates Thereof
CA3042442C (en) * 2016-11-14 2024-01-02 Hangzhou Dac Biotech Co., Ltd Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses of such conjugates with the linkers

Similar Documents

Publication Publication Date Title
US10632131B2 (en) Controlled release system
JP2009542649A5 (https=)
CN106470672B (zh) 包括吉西他滨前药的制剂
JP4869594B2 (ja) 癌治療のための小胞封入コルチコステロイド
US12357652B2 (en) Formulations of phosphoramidate derivatives of nucleoside drugs
CN116867500A (zh) 两性离子脂质纳米颗粒组合物和使用方法
JP2020512336A5 (https=)
HRP20161268T1 (hr) Kombinirani preparat koji se sastoji od egzozoma i kortikosteroida
KR102811484B1 (ko) 치료 덴드리머
US9993487B2 (en) Cyclodextrin and budesonide derivative compositions and methods
JP2015506983A5 (https=)
TW202140073A (zh) 玻尿酸衍生物、醫藥組合物及玻尿酸衍生物－藥物結合體
JP2017502984A5 (https=)
US11623009B2 (en) Bone fracture repair by targeting of agents that promote bone healing
JPWO2021142145A5 (https=)
JP4564844B2 (ja) 炎症性疾患の治療用組成物
JP2021505550A5 (https=)
JP5661985B2 (ja) 無菌性水性懸濁製剤
JP2007515425A (ja) 医薬組成物
JP2022533189A (ja) 混合高分子ミセルを含有する医薬組成物
WO2008075706A1 (ja) 間質性肺炎治療剤
WO2006122542A2 (de) Nicht virales vektorsystem zum transport von nukleinsäure in die lunge
JP2021522172A5 (https=)
CN114174318A (zh) 生物降解性优异的肾靶向型药物递送用载体
JPWO2023137403A5 (https=)